Nina Lind1, Anna Söderholm, Eva Palmquist, Linus Andersson, Eva Millqvist, Steven Nordin. 1. Department of Psychology, Umeå University, Umeå (Drs Lind, Söderholm, Palmquist, Andersson, Nordin); Department of Economics, Swedish University of Agricultural Sciences (Dr Lind); Department of Occupational and Public Health Sciences, University of Gävle, Gävle (Dr Andersson); and Asthma and Allergy Research Group, Sahlgrenska University Hospital, Gothenburg, Sweden (Dr Millqvist).
Abstract
OBJECTIVES: We tested the hypothesis of high comorbidity between asthma/allergy and chemical intolerance (CI) and between asthma/allergy and building intolerance (BI), and high multimorbidity between asthma/allergy, CI, and BI. METHODS: Population-based questionnaire data were used from 530 participants with asthma/allergy (allergic asthma, nonallergic asthma, allergic rhinitis, and/or atopic dermatitis), 414 with self-reported and 112 with physician-diagnosed CI, and 165 with self-reported and 47 with physician-diagnosed BI. Separate reference groups were formed for each of the five case groups. RESULTS: Adjusted odds ratios varied from 4.6 to 13.1 for comorbidity, and from 6.6 to 46.4 for multimorbidity. CONCLUSION: The large comorbidity and multimorbidity between asthma/allergy, CI, and BI evokes the question as to whether there are similarities in underlying mechanisms between these conditions.
OBJECTIVES: We tested the hypothesis of high comorbidity between asthma/allergy and chemical intolerance (CI) and between asthma/allergy and building intolerance (BI), and high multimorbidity between asthma/allergy, CI, and BI. METHODS: Population-based questionnaire data were used from 530 participants with asthma/allergy (allergic asthma, nonallergic asthma, allergic rhinitis, and/or atopic dermatitis), 414 with self-reported and 112 with physician-diagnosed CI, and 165 with self-reported and 47 with physician-diagnosed BI. Separate reference groups were formed for each of the five case groups. RESULTS: Adjusted odds ratios varied from 4.6 to 13.1 for comorbidity, and from 6.6 to 46.4 for multimorbidity. CONCLUSION: The large comorbidity and multimorbidity between asthma/allergy, CI, and BI evokes the question as to whether there are similarities in underlying mechanisms between these conditions.
Authors: Kirsi Karvala; Markku Sainio; Eva Palmquist; Anna-Sara Claeson; Maj-Helen Nyback; Steven Nordin Journal: Int J Environ Res Public Health Date: 2018-09-19 Impact factor: 3.390
Authors: Pia Nynäs; Sarkku Vilpas; Elina Kankare; Jussi Karjalainen; Lauri Lehtimäki; Jura Numminen; Antti Tikkakoski; Leenamaija Kleemola; Heini Huhtala; Jukka Uitti Journal: Int J Environ Res Public Health Date: 2021-11-23 Impact factor: 3.390